INTUITIVE SURGICAL INC·4

Feb 27, 2:00 PM ET

Curet Myriam 4

4 · INTUITIVE SURGICAL INC · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Intuitive Surgical (ISRG) EVP Myriam Curet Exercises RSUs/PSUs, Shares Withheld

What Happened

  • Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, had restricted stock units (RSUs) and performance stock units (PSUs) convert to common stock on February 26, 2026. A total of vested/converted units included 3,052 and 1,602 share conversions plus a grant/award of 2,793 RSUs.
  • To satisfy tax withholding obligations, 1,514 shares and 795 shares were withheld (disposed) at an effective price of $506.17 per share, totaling $766,341 and $402,405 respectively — about $1,168,746 in aggregate. The net shares were deposited into the holder’s account per the footnotes.
  • These transactions are routine vesting/conversion and tax-withholding events rather than open-market sales or purchases.

Key Details

  • Transaction date: February 26, 2026.
  • Withheld (disposed) shares for tax: 1,514 @ $506.17 = $766,341; 795 @ $506.17 = $402,405. Total withheld value ≈ $1,168,746.
  • Converted/acquired (derivative conversions or awards): 3,052 shares (conversion), 1,602 shares (conversion), and a grant/award of 2,793 RSUs (derivative).
  • Shares owned after the transactions: Not disclosed in the provided Form 4 excerpt.
  • Notable footnotes: RSUs vest per stated schedules (some vest 33% annually; some vest 100% on first anniversary). PSUs granted Feb 28, 2023 met performance criteria and vested on Feb 28, 2026. Portions of vested shares were held back to cover statutory tax withholding; net shares deposited to the holder’s account.
  • Filing timeliness: Form filed Feb 27, 2026 reporting transactions on Feb 26, 2026 (no late filing indicated).

Context

  • These filings reflect vesting/conversion of equity awards and a common "sell-to-cover" (share withholding) to satisfy tax obligations — not an open-market sale signaling a directional trade. For retail investors, purchases are generally more informative than routine vesting/tax-withholding events; here the material action is the recognition of vested equity and the associated tax withholding of ~2,309 shares.

Insider Transaction Report

Form 4
Period: 2026-02-26
Curet Myriam
EVP & Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-26+3,0523,461 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    [F1]
    2026-02-26$506.17/sh1,514$766,3411,947 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-02-26+1,6023,549 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    [F2]
    2026-02-26$506.17/sh795$402,4052,754 total(indirect: By Trust)
  • Award

    Performance Stock Units - 2-28-2023

    [F3]
    2026-02-26+2,7938,378 total
    Exercise: $0.00Common Stock (2,793 underlying)
  • Exercise/Conversion

    Restricted Stock Units - 2-26-2024

    [F4]
    2026-02-263,0523,053 total
    Exercise: $0.00Common Stock (3,052 underlying)
  • Exercise/Conversion

    Restricted Stock Units - 2-26-2025

    [F5]
    2026-02-261,6020 total
    Exercise: $0.00Common Stock (1,602 underlying)
Footnotes (5)
  • [F1]RSUs vest 33% per year over a three year period. RSUs convert into common stock on the vest date on a one-for-one basis. 33% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
  • [F2]RSUs vest 100% on the first anniversary of the date of grant. RSUs convert into common stock on the vest date on a one-for-one basis. 100% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
  • [F3]Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
  • [F4]Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 33% on the first anniversary of the date of grant and annually thereafter, over a three year period of time.
  • [F5]Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 100% on the first anniversary of the date of grant.
Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet|2026-02-27

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT